Alnylam Pharmaceuticals (ALNY) Stock Forecast for 2023 – 2026. Sell or Buy Prediction

Alnylam Pharmaceuticals (ALNY) Stock Forecast for 2023 – 2026. Sell or Buy?

Last update: May 11, 2023 (18:47)

Sector: Healthcare

The share price of Alnylam Pharmaceuticals, Inc. (ALNY) now

What analysts predict: $247.86
52-week High/Low: $242.97 / $178.21

50/200 Day Moving Average: $194.28 / $204.72

This figure corresponds to the Average Price over the previous 50/200 days. For Alnylam Pharmaceuticals stocks, the 50-day moving average is the resistance level today.

For Alnylam Pharmaceuticals stocks, the 200-day moving average is the resistance level today.

Are you interested in Alnylam Pharmaceuticals, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Alnylam Pharmaceuticals stock price in 2023, 2024, 2025, 2026, 2027. How much will one Alnylam Pharmaceuticals share be worth in 2023 - 2027?

When should I take profit in Alnylam Pharmaceuticals stock? When should I record a loss on Alnylam Pharmaceuticals stock? What are analysts' forecasts for Alnylam Pharmaceuticals stock? What is the future of Alnylam Pharmaceuticals stock? We forecast Alnylam Pharmaceuticals stock performance using neural networks based on historical data on Alnylam Pharmaceuticals stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Alnylam Pharmaceuticals stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2023, 2024, 2025, 2026 and 2027) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Alnylam Pharmaceuticals shares. This happens once a day.




Historical and forecast chart of Alnylam Pharmaceuticals stock

The chart below shows the historical price of Alnylam Pharmaceuticals stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Alnylam Pharmaceuticals stock price can be found in the table below.

Long-term forecasts by years.

Alnylam Pharmaceuticals daily forecast for a month

Date Target Pes. Opt. Vol., %
May 29 129.75 127.62 130.42 2.19
May 30 130.32 128.56 131.00 1.90
May 31 129.31 128.20 130.75 1.99
Jun 01 125.94 123.72 127.12 2.75
Jun 02 128.40 125.73 129.43 2.95
Jun 03 127.80 126.04 129.49 2.74
Jun 04 127.27 125.68 129.52 3.05
Jun 05 125.65 123.95 127.51 2.87
Jun 06 127.77 126.67 129.33 2.10
Jun 07 128.93 126.32 131.21 3.88
Jun 08 130.47 129.12 133.09 3.07
Jun 09 133.09 131.87 133.95 1.57
Jun 10 134.40 132.27 135.69 2.59
Jun 11 133.81 132.07 135.58 2.66
Jun 12 133.63 131.27 135.96 3.57
Jun 13 137.11 135.11 138.21 2.30
Jun 14 136.00 133.17 137.81 3.48
Jun 15 135.75 134.55 136.85 1.70
Jun 16 135.61 132.93 137.59 3.50
Jun 17 133.50 132.80 135.48 2.01
Jun 18 134.96 132.67 137.20 3.41
Jun 19 136.71 134.79 139.16 3.24
Jun 20 139.87 137.65 141.51 2.80
Jun 21 141.58 138.90 142.83 2.84
Jun 22 140.88 138.80 143.52 3.40
Jun 23 140.92 138.72 141.73 2.17
Jun 24 142.31 139.98 144.53 3.25
Jun 25 141.94 139.80 142.68 2.06
Jun 26 142.98 140.52 145.43 3.49
Jun 27 141.82 139.46 143.41 2.83

Alnylam Pharmaceuticals Daily Price Targets


Alnylam Pharmaceuticals Stock Forecast 05-29-2022.

Forecast target price for 05-29-2022: $129.75.
Negative dynamics for Alnylam Pharmaceuticals shares will prevail with possible volatility of 2.147%.
Pessimistic target level: 127.62
Optimistic target level: 130.42

Alnylam Pharmaceuticals Stock Forecast 05-30-2022.

Forecast target price for 05-30-2022: $130.32.
Positive dynamics for Alnylam Pharmaceuticals shares will prevail with possible volatility of 1.863%.
Pessimistic target level: 128.56
Optimistic target level: 131.00

Alnylam Pharmaceuticals Stock Forecast 05-31-2022.

Forecast target price for 05-31-2022: $129.31.
Negative dynamics for Alnylam Pharmaceuticals shares will prevail with possible volatility of 1.955%.
Pessimistic target level: 128.20
Optimistic target level: 130.75

Alnylam Pharmaceuticals Stock Forecast 06-01-2022.

Forecast target price for 06-01-2022: $125.94.
Negative dynamics for Alnylam Pharmaceuticals shares will prevail with possible volatility of 2.679%.
Pessimistic target level: 123.72
Optimistic target level: 127.12

Alnylam Pharmaceuticals Stock Forecast 06-02-2022.

Forecast target price for 06-02-2022: $128.40.
Positive dynamics for Alnylam Pharmaceuticals shares will prevail with possible volatility of 2.863%.
Pessimistic target level: 125.73
Optimistic target level: 129.43

Alnylam Pharmaceuticals Stock Forecast 06-03-2022.

Forecast target price for 06-03-2022: $127.80.
Negative dynamics for Alnylam Pharmaceuticals shares will prevail with possible volatility of 2.669%.
Pessimistic target level: 126.04
Optimistic target level: 129.49

ALNY (ALNY) Monthly Stock Prediction for 2023

Month Target Pes. Opt. Vol., %
Oct. 188.27 178.33 197.18 9.56
Nov. 181.23 176.85 186.61 5.23
Dec. 176.05 160.56 182.83 12.18

Alnylam Pharmaceuticals forecast for this year


Alnylam Pharmaceuticals Stock Prediction for Oct 2023

An uptrend is forecast for this month with an optimal target price of $188.273. Pessimistic: $178.33. Optimistic: $197.18


Alnylam Pharmaceuticals Stock Prediction for Nov 2023

An downtrend is forecast for this month with an optimal target price of $181.232. Pessimistic: $176.85. Optimistic: $186.61


Alnylam Pharmaceuticals Stock Prediction for Dec 2023

An downtrend is forecast for this month with an optimal target price of $176.048. Pessimistic: $160.56. Optimistic: $182.83



Alnylam Pharmaceuticals (ALNY) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jan 178.18 165.05 182.49 9.56
Feb 185.82 177.24 200.74 11.71
Mar 180.10 168.21 188.22 10.63
Apr 199.12 191.89 213.57 10.15
May 190.58 181.35 205.88 11.91
Jun 192.25 176.39 202.83 13.03
Jul 209.38 199.71 218.60 8.64
Aug 216.52 211.52 228.19 7.31
Sep 211.76 200.11 221.54 9.67
Oct 210.59 192.29 226.35 15.05
Nov 215.46 203.37 233.71 12.98
Dec 212.85 198.80 225.50 11.84

Alnylam Pharmaceuticals (ALNY) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 203.02 187.83 213.74 12.12
Feb 206.59 196.59 214.09 8.17
Mar 224.32 214.69 232.95 7.84
Apr 231.47 223.83 249.55 10.30
May 217.72 206.71 225.87 8.48
Jun 200.48 195.85 214.37 8.64
Jul 201.14 188.53 206.89 8.88
Aug 199.59 192.13 210.13 8.57
Sep 215.62 198.54 231.99 14.42
Oct 222.74 211.95 229.60 7.68
Nov 223.23 205.79 229.85 10.47
Dec 230.35 218.94 241.24 9.24

Alnylam Pharmaceuticals (ALNY) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 230.09 223.26 236.17 5.47
Feb 226.55 207.36 241.50 14.14
Mar 212.34 206.27 227.53 9.34
Apr 213.75 206.22 221.98 7.10
May 222.68 213.86 232.48 8.01
Jun 230.27 218.12 241.42 9.65
Jul 238.38 231.30 245.98 5.97
Aug 237.59 230.28 256.93 10.38
Sep 239.42 233.37 253.64 8.00
Oct 238.11 219.25 251.20 12.72
Nov 254.87 240.57 269.17 10.62
Dec 262.16 248.60 268.79 7.51

Alnylam Pharmaceuticals (ALNY) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 275.42 257.85 288.15 10.51
Feb 249.97 239.52 271.70 11.84
Mar 246.67 235.28 259.43 9.31
Apr 256.44 249.95 278.45 10.23
May 256.16 235.31 276.45 14.88
Jun 256.72 235.26 275.36 14.56
Jul 274.23 253.42 298.06 14.98
Aug 266.09 259.94 282.19 7.88
Sep 276.92 267.17 290.93 8.17
Oct 295.50 276.32 313.05 11.73
Nov 327.68 309.66 353.99 12.52
Dec 336.69 328.91 345.58 4.82

Alnylam Pharmaceuticals information and performance

Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, is engaged in the discovery, development and commercialization of RNA interference (RNAi) therapeutics. The company’s line of investigated RNAi therapies focuses on genetic drugs, cardiovascular diseases, liver infections, and central nervous system (CNS) / eye diseases.

Alnylam Pharmaceuticals Address

675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA, US

Market Capitalization: 22 987 684 000 $

Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.

EBITDA: -774 137 024 $

EBITDA is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: -0.49

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -8.27

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: 0.418
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 28.64

Enterprise Value (EV) /Revenue

EV To EBITDA: -29.42

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 125001000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.